Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZBTB14
|
ENSG00000198081.6 | zinc finger and BTB domain containing 14 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_5311502_5311653 | ZBTB14 | 14525 | 0.257691 | 0.84 | 4.9e-03 | Click! |
chr18_5294073_5294326 | ZBTB14 | 624 | 0.816348 | -0.63 | 6.7e-02 | Click! |
chr18_5294330_5295063 | ZBTB14 | 127 | 0.977662 | -0.59 | 9.3e-02 | Click! |
chr18_5297030_5297270 | ZBTB14 | 98 | 0.981313 | -0.44 | 2.4e-01 | Click! |
chr18_5310354_5310583 | ZBTB14 | 13416 | 0.260909 | -0.39 | 3.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_48462552_48463006 | 2.45 |
TRABD2B |
TraB domain containing 2B |
212 |
0.96 |
chr13_93879365_93880233 | 2.44 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr1_15479287_15480043 | 2.05 |
TMEM51 |
transmembrane protein 51 |
564 |
0.8 |
chr2_139537425_139537878 | 1.61 |
NXPH2 |
neurexophilin 2 |
267 |
0.95 |
chr8_494526_494820 | 1.52 |
TDRP |
testis development related protein |
164 |
0.97 |
chr16_85203170_85204140 | 1.47 |
CTC-786C10.1 |
|
1227 |
0.55 |
chr2_79739509_79740065 | 1.43 |
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
339 |
0.91 |
chr2_17719788_17720723 | 1.42 |
VSNL1 |
visinin-like 1 |
138 |
0.97 |
chr5_168727419_168727744 | 1.38 |
SLIT3 |
slit homolog 3 (Drosophila) |
132 |
0.98 |
chr7_121513003_121513376 | 1.37 |
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
46 |
0.99 |
chr17_12568379_12568897 | 1.37 |
MYOCD |
myocardin |
668 |
0.75 |
chr12_32551927_32552214 | 1.36 |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
393 |
0.86 |
chr5_111755026_111755253 | 1.35 |
EPB41L4A |
erythrocyte membrane protein band 4.1 like 4A |
126 |
0.52 |
chr3_61547142_61547508 | 1.33 |
PTPRG |
protein tyrosine phosphatase, receptor type, G |
260 |
0.96 |
chr1_66258526_66259233 | 1.27 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
15 |
0.99 |
chr5_131593477_131594185 | 1.25 |
PDLIM4 |
PDZ and LIM domain 4 |
431 |
0.81 |
chr20_9049623_9049963 | 1.24 |
PLCB4 |
phospholipase C, beta 4 |
45 |
0.98 |
chr14_70346080_70346697 | 1.23 |
SMOC1 |
SPARC related modular calcium binding 1 |
245 |
0.95 |
chr22_46933754_46934840 | 1.21 |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
1230 |
0.46 |
chr5_9544908_9545592 | 1.20 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
937 |
0.56 |
chr9_17578628_17579355 | 1.20 |
SH3GL2 |
SH3-domain GRB2-like 2 |
130 |
0.98 |
chr7_45960469_45960882 | 1.18 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
175 |
0.95 |
chr11_94473290_94474384 | 1.17 |
RP11-867G2.8 |
|
316 |
0.92 |
chr9_23821130_23821679 | 1.17 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
74 |
0.99 |
chr2_29338259_29338523 | 1.13 |
CLIP4 |
CAP-GLY domain containing linker protein family, member 4 |
99 |
0.96 |
chr8_69242814_69243988 | 1.13 |
C8orf34 |
chromosome 8 open reading frame 34 |
56 |
0.82 |
chr20_49347136_49348386 | 1.13 |
PARD6B |
par-6 family cell polarity regulator beta |
320 |
0.89 |
chr17_12693066_12693649 | 1.12 |
RP11-1090M7.1 |
|
202 |
0.59 |
chr15_90197878_90198651 | 1.12 |
KIF7 |
kinesin family member 7 |
418 |
0.77 |
chr12_52701821_52702383 | 1.12 |
RP11-845M18.6 |
|
53 |
0.94 |
chr4_81189244_81189728 | 1.10 |
FGF5 |
fibroblast growth factor 5 |
1693 |
0.45 |
chr3_44036429_44037293 | 1.10 |
ENSG00000252980 |
. |
75718 |
0.11 |
chr1_14924992_14926197 | 1.08 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr22_41633466_41634617 | 1.07 |
CHADL |
chondroadherin-like |
1584 |
0.26 |
chr1_36038675_36039393 | 1.07 |
TFAP2E |
transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon) |
63 |
0.8 |
chr18_7117321_7117760 | 1.07 |
LAMA1 |
laminin, alpha 1 |
273 |
0.94 |
chr11_111169649_111170452 | 1.06 |
COLCA2 |
colorectal cancer associated 2 |
74 |
0.88 |
chr9_109623689_109623898 | 1.04 |
ZNF462 |
zinc finger protein 462 |
1585 |
0.44 |
chr2_235861126_235861866 | 1.04 |
SH3BP4 |
SH3-domain binding protein 4 |
776 |
0.8 |
chr13_23733598_23733940 | 1.01 |
ENSG00000207157 |
. |
6944 |
0.23 |
chr15_61519867_61520036 | 1.00 |
RORA |
RAR-related orphan receptor A |
1567 |
0.44 |
chr20_35490580_35491167 | 0.99 |
SOGA1 |
suppressor of glucose, autophagy associated 1 |
1216 |
0.43 |
chr1_65774988_65775539 | 0.99 |
DNAJC6 |
DnaJ (Hsp40) homolog, subfamily C, member 6 |
35 |
0.98 |
chr4_5053247_5053862 | 0.99 |
STK32B |
serine/threonine kinase 32B |
385 |
0.9 |
chr5_127872787_127873476 | 0.99 |
FBN2 |
fibrillin 2 |
383 |
0.63 |
chr9_113800173_113800351 | 0.97 |
LPAR1 |
lysophosphatidic acid receptor 1 |
61 |
0.98 |
chr9_109624363_109624788 | 0.96 |
ZNF462 |
zinc finger protein 462 |
803 |
0.69 |
chr17_37856067_37857084 | 0.95 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr2_200320371_200320723 | 0.95 |
SATB2 |
SATB homeobox 2 |
264 |
0.92 |
chr8_494269_494491 | 0.95 |
TDRP |
testis development related protein |
457 |
0.88 |
chr3_8809480_8810320 | 0.95 |
OXTR |
oxytocin receptor |
463 |
0.76 |
chr8_25904244_25904423 | 0.94 |
EBF2 |
early B-cell factor 2 |
1420 |
0.57 |
chr3_55520023_55520469 | 0.93 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
1085 |
0.48 |
chr11_132813237_132813595 | 0.92 |
OPCML |
opioid binding protein/cell adhesion molecule-like |
150 |
0.98 |
chr2_121494510_121494857 | 0.91 |
GLI2 |
GLI family zinc finger 2 |
860 |
0.74 |
chr19_30719772_30720177 | 0.91 |
AC005597.1 |
|
352 |
0.63 |
chr13_114540399_114540680 | 0.91 |
GAS6 |
growth arrest-specific 6 |
1522 |
0.45 |
chr7_33945201_33945548 | 0.91 |
BMPER |
BMP binding endothelial regulator |
229 |
0.96 |
chr8_94712271_94712761 | 0.90 |
FAM92A1 |
family with sequence similarity 92, member A1 |
36 |
0.63 |
chrX_153031383_153031900 | 0.90 |
U52111.14 |
|
267 |
0.71 |
chr3_127633934_127634403 | 0.89 |
KBTBD12 |
kelch repeat and BTB (POZ) domain containing 12 |
93 |
0.98 |
chr20_9048816_9049419 | 0.88 |
PLCB4 |
phospholipase C, beta 4 |
293 |
0.9 |
chr2_14772413_14772680 | 0.88 |
FAM84A |
family with sequence similarity 84, member A |
264 |
0.93 |
chr11_8832007_8832297 | 0.88 |
ST5 |
suppression of tumorigenicity 5 |
44 |
0.97 |
chr6_17101754_17102792 | 0.88 |
STMND1 |
stathmin domain containing 1 |
216 |
0.97 |
chr4_145567169_145567691 | 0.87 |
HHIP |
hedgehog interacting protein |
106 |
0.75 |
chr14_86000288_86000530 | 0.87 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
3837 |
0.29 |
chr9_130639317_130639975 | 0.87 |
AK1 |
adenylate kinase 1 |
376 |
0.71 |
chr20_23617810_23618640 | 0.86 |
CST3 |
cystatin C |
357 |
0.87 |
chr10_103326247_103326406 | 0.86 |
DPCD |
deleted in primary ciliary dyskinesia homolog (mouse) |
4080 |
0.2 |
chr2_206549618_206550045 | 0.86 |
NRP2 |
neuropilin 2 |
1816 |
0.48 |
chr3_125985987_125986785 | 0.86 |
ALDH1L1-AS2 |
ALDH1L1 antisense RNA 2 |
60288 |
0.1 |
chr18_52626293_52626952 | 0.85 |
CCDC68 |
coiled-coil domain containing 68 |
117 |
0.97 |
chr2_23608861_23609561 | 0.85 |
KLHL29 |
kelch-like family member 29 |
1123 |
0.67 |
chr7_116963139_116963425 | 0.84 |
WNT2 |
wingless-type MMTV integration site family member 2 |
61 |
0.98 |
chr10_50969933_50970461 | 0.84 |
OGDHL |
oxoglutarate dehydrogenase-like |
172 |
0.97 |
chr20_53092350_53092560 | 0.84 |
DOK5 |
docking protein 5 |
198 |
0.97 |
chr14_89020611_89020920 | 0.84 |
PTPN21 |
protein tyrosine phosphatase, non-receptor type 21 |
312 |
0.86 |
chr16_65157518_65157704 | 0.84 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1343 |
0.63 |
chr6_124125020_124125494 | 0.84 |
NKAIN2 |
Na+/K+ transporting ATPase interacting 2 |
29 |
0.98 |
chr13_27131903_27132772 | 0.84 |
WASF3 |
WAS protein family, member 3 |
450 |
0.89 |
chr3_133614384_133614662 | 0.83 |
RAB6B |
RAB6B, member RAS oncogene family |
46 |
0.98 |
chr1_33366734_33367013 | 0.83 |
TMEM54 |
transmembrane protein 54 |
86 |
0.96 |
chr1_33336564_33337052 | 0.83 |
FNDC5 |
fibronectin type III domain containing 5 |
394 |
0.8 |
chr18_32073953_32074215 | 0.82 |
DTNA |
dystrobrevin, alpha |
217 |
0.97 |
chr8_15094580_15095009 | 0.81 |
SGCZ |
sarcoglycan, zeta |
1054 |
0.7 |
chr2_18059226_18059712 | 0.79 |
KCNS3 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
355 |
0.91 |
chr9_79520622_79521003 | 0.78 |
PRUNE2 |
prune homolog 2 (Drosophila) |
189 |
0.97 |
chr7_124405949_124406114 | 0.78 |
GPR37 |
G protein-coupled receptor 37 (endothelin receptor type B-like) |
350 |
0.92 |
chr5_171880596_171880995 | 0.77 |
SH3PXD2B |
SH3 and PX domains 2B |
567 |
0.79 |
chr21_31311288_31312406 | 0.77 |
GRIK1 |
glutamate receptor, ionotropic, kainate 1 |
3 |
0.99 |
chr2_110656312_110656910 | 0.77 |
LIMS3 |
LIM and senescent cell antigen-like domains 3 |
343 |
0.93 |
chr10_122216781_122217284 | 0.77 |
PPAPDC1A |
phosphatidic acid phosphatase type 2 domain containing 1A |
273 |
0.93 |
chr19_1315736_1316102 | 0.76 |
EFNA2 |
ephrin-A2 |
29766 |
0.07 |
chr12_59314085_59314286 | 0.76 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
118 |
0.67 |
chr4_24913981_24914389 | 0.76 |
CCDC149 |
coiled-coil domain containing 149 |
323 |
0.94 |
chr19_8400013_8400372 | 0.76 |
KANK3 |
KN motif and ankyrin repeat domains 3 |
7954 |
0.1 |
chr16_10276697_10276872 | 0.76 |
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
173 |
0.97 |
chr1_224803774_224804760 | 0.76 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
272 |
0.57 |
chr19_54982774_54982958 | 0.75 |
CDC42EP5 |
CDC42 effector protein (Rho GTPase binding) 5 |
1545 |
0.21 |
chr19_49339481_49339819 | 0.75 |
HSD17B14 |
hydroxysteroid (17-beta) dehydrogenase 14 |
117 |
0.92 |
chr10_116164052_116164623 | 0.75 |
AFAP1L2 |
actin filament associated protein 1-like 2 |
77 |
0.98 |
chr1_205648469_205649627 | 0.75 |
SLC45A3 |
solute carrier family 45, member 3 |
539 |
0.74 |
chr2_109271526_109272143 | 0.75 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
325 |
0.91 |
chr7_96654173_96654357 | 0.74 |
DLX5 |
distal-less homeobox 5 |
3 |
0.97 |
chr2_237072978_237073169 | 0.74 |
AC079135.1 |
|
3017 |
0.2 |
chrX_107179250_107179655 | 0.74 |
RP6-191P20.4 |
|
242 |
0.93 |
chr22_37914692_37915408 | 0.74 |
CARD10 |
caspase recruitment domain family, member 10 |
197 |
0.92 |
chr6_117586821_117587180 | 0.73 |
VGLL2 |
vestigial like 2 (Drosophila) |
263 |
0.92 |
chr16_66878332_66879083 | 0.72 |
CA7 |
carbonic anhydrase VII |
128 |
0.94 |
chr3_116163803_116163967 | 0.72 |
LSAMP |
limbic system-associated membrane protein |
55 |
0.99 |
chr11_706284_706488 | 0.72 |
EPS8L2 |
EPS8-like 2 |
149 |
0.89 |
chr8_11205173_11205793 | 0.72 |
AF131216.5 |
|
472 |
0.72 |
chr18_6729547_6730123 | 0.72 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr12_45444664_45445224 | 0.71 |
DBX2 |
developing brain homeobox 2 |
62 |
0.76 |
chr5_71404572_71404741 | 0.71 |
MAP1B |
microtubule-associated protein 1B |
1343 |
0.56 |
chr19_4584366_4584890 | 0.71 |
SEMA6B |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
24808 |
0.09 |
chr2_159825200_159826543 | 0.71 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr5_124070851_124071458 | 0.71 |
RP11-436H11.5 |
|
286 |
0.82 |
chr1_167408487_167409140 | 0.70 |
RP11-104L21.2 |
|
19085 |
0.19 |
chr5_10306978_10307734 | 0.69 |
CMBL |
carboxymethylenebutenolidase homolog (Pseudomonas) |
782 |
0.53 |
chr12_58131774_58132107 | 0.69 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
89 |
0.91 |
chr11_79148234_79148400 | 0.69 |
TENM4 |
teneurin transmembrane protein 4 |
3378 |
0.27 |
chr11_91958171_91958481 | 0.69 |
FAT3 |
FAT atypical cadherin 3 |
126936 |
0.06 |
chr7_89841111_89841428 | 0.69 |
STEAP2 |
STEAP family member 2, metalloreductase |
24 |
0.82 |
chr3_28616803_28617040 | 0.69 |
LINC00693 |
long intergenic non-protein coding RNA 693 |
639 |
0.82 |
chr4_108852670_108853394 | 0.69 |
RP11-286E11.1 |
|
243 |
0.53 |
chr8_142010048_142010787 | 0.69 |
PTK2 |
protein tyrosine kinase 2 |
619 |
0.8 |
chr19_36912260_36913005 | 0.69 |
ZFP82 |
ZFP82 zinc finger protein |
3074 |
0.19 |
chr7_100342894_100343080 | 0.68 |
ZAN |
zonadhesin (gene/pseudogene) |
11343 |
0.11 |
chr5_2748257_2748559 | 0.68 |
IRX2 |
iroquois homeobox 2 |
3361 |
0.29 |
chr5_89854556_89855048 | 0.68 |
GPR98 |
G protein-coupled receptor 98 |
185 |
0.96 |
chr8_120220220_120220504 | 0.68 |
MAL2 |
mal, T-cell differentiation protein 2 (gene/pseudogene) |
248 |
0.96 |
chr11_91959345_91959603 | 0.67 |
FAT3 |
FAT atypical cadherin 3 |
125788 |
0.06 |
chr13_61988719_61988961 | 0.67 |
PCDH20 |
protocadherin 20 |
815 |
0.78 |
chr12_54611665_54611918 | 0.67 |
ENSG00000265371 |
. |
13469 |
0.1 |
chr6_83073110_83073416 | 0.67 |
TPBG |
trophoblast glycoprotein |
85 |
0.98 |
chrX_38079311_38080259 | 0.67 |
SRPX |
sushi-repeat containing protein, X-linked |
367 |
0.75 |
chr13_78493097_78493683 | 0.67 |
EDNRB |
endothelin receptor type B |
424 |
0.48 |
chr12_2163394_2163601 | 0.67 |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
768 |
0.61 |
chr10_71812550_71812868 | 0.67 |
H2AFY2 |
H2A histone family, member Y2 |
73 |
0.98 |
chr11_11642193_11642674 | 0.66 |
GALNT18 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18 |
1119 |
0.56 |
chr11_61684550_61685041 | 0.66 |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
202 |
0.91 |
chr20_4129930_4130735 | 0.66 |
SMOX |
spermine oxidase |
750 |
0.71 |
chr3_170136599_170137401 | 0.66 |
CLDN11 |
claudin 11 |
145 |
0.97 |
chr2_122042196_122043145 | 0.66 |
TFCP2L1 |
transcription factor CP2-like 1 |
113 |
0.98 |
chr5_37838531_37838751 | 0.66 |
GDNF |
glial cell derived neurotrophic factor |
1141 |
0.59 |
chr4_110223153_110224430 | 0.65 |
COL25A1 |
collagen, type XXV, alpha 1 |
8 |
0.99 |
chr9_114361613_114362271 | 0.65 |
PTGR1 |
prostaglandin reductase 1 |
33 |
0.97 |
chr13_100636014_100636165 | 0.65 |
ZIC2 |
Zic family member 2 |
2063 |
0.31 |
chr12_115109503_115109744 | 0.65 |
TBX3 |
T-box 3 |
11772 |
0.21 |
chr19_41104181_41104507 | 0.65 |
LTBP4 |
latent transforming growth factor beta binding protein 4 |
1203 |
0.38 |
chrX_36975622_36976198 | 0.65 |
FAM47C |
family with sequence similarity 47, member C |
50522 |
0.19 |
chr18_72916223_72916374 | 0.65 |
ZADH2 |
zinc binding alcohol dehydrogenase domain containing 2 |
1170 |
0.57 |
chr11_106889276_106889822 | 0.64 |
GUCY1A2 |
guanylate cyclase 1, soluble, alpha 2 |
299 |
0.95 |
chr10_79470838_79471281 | 0.64 |
ENSG00000199664 |
. |
65754 |
0.1 |
chr17_3848324_3848628 | 0.64 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
14811 |
0.16 |
chr8_124171100_124171251 | 0.64 |
FAM83A |
family with sequence similarity 83, member A |
20112 |
0.11 |
chr11_47611407_47611847 | 0.64 |
C1QTNF4 |
C1q and tumor necrosis factor related protein 4 |
735 |
0.43 |
chr9_137536865_137537048 | 0.64 |
COL5A1 |
collagen, type V, alpha 1 |
3336 |
0.26 |
chr19_46974752_46975184 | 0.63 |
PNMAL1 |
paraneoplastic Ma antigen family-like 1 |
148 |
0.94 |
chr8_49782515_49783288 | 0.63 |
SNAI2 |
snail family zinc finger 2 |
51087 |
0.18 |
chr10_118031771_118032060 | 0.63 |
GFRA1 |
GDNF family receptor alpha 1 |
121 |
0.98 |
chr2_75787048_75787447 | 0.63 |
EVA1A |
eva-1 homolog A (C. elegans) |
792 |
0.61 |
chr13_96295981_96296211 | 0.62 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
579 |
0.79 |
chr21_33244856_33245438 | 0.62 |
HUNK |
hormonally up-regulated Neu-associated kinase |
481 |
0.88 |
chr12_28128015_28128311 | 0.62 |
PTHLH |
parathyroid hormone-like hormone |
2525 |
0.32 |
chr8_89340038_89340774 | 0.62 |
MMP16 |
matrix metallopeptidase 16 (membrane-inserted) |
152 |
0.73 |
chr11_43965819_43966142 | 0.61 |
C11orf96 |
chromosome 11 open reading frame 96 |
1925 |
0.3 |
chr1_32042075_32042226 | 0.60 |
TINAGL1 |
tubulointerstitial nephritis antigen-like 1 |
11 |
0.95 |
chr10_18428938_18429504 | 0.60 |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
385 |
0.91 |
chr11_33397184_33397561 | 0.60 |
ENSG00000223134 |
. |
21361 |
0.24 |
chr22_46366779_46367595 | 0.60 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
1408 |
0.38 |
chr3_44063258_44064101 | 0.60 |
ENSG00000252980 |
. |
48900 |
0.17 |
chr4_4867748_4868284 | 0.59 |
MSX1 |
msh homeobox 1 |
6623 |
0.28 |
chr7_45614270_45614575 | 0.59 |
ADCY1 |
adenylate cyclase 1 (brain) |
301 |
0.94 |
chr12_28128342_28128815 | 0.59 |
PTHLH |
parathyroid hormone-like hormone |
2940 |
0.29 |
chr19_49653084_49654050 | 0.59 |
PPFIA3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
2209 |
0.15 |
chr16_54318004_54318459 | 0.59 |
IRX3 |
iroquois homeobox 3 |
1536 |
0.47 |
chr15_72476680_72477103 | 0.59 |
GRAMD2 |
GRAM domain containing 2 |
13235 |
0.15 |
chr6_43044172_43044516 | 0.58 |
PTK7 |
protein tyrosine kinase 7 |
208 |
0.85 |
chr12_71003154_71004126 | 0.58 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
16 |
0.99 |
chr1_26488543_26488704 | 0.58 |
FAM110D |
family with sequence similarity 110, member D |
3112 |
0.13 |
chr1_57887983_57888200 | 0.58 |
DAB1 |
Dab, reelin signal transducer, homolog 1 (Drosophila) |
1638 |
0.56 |
chr3_112929944_112930573 | 0.58 |
BOC |
BOC cell adhesion associated, oncogene regulated |
71 |
0.98 |
chr4_158141606_158141785 | 0.58 |
GRIA2 |
glutamate receptor, ionotropic, AMPA 2 |
125 |
0.97 |
chr19_460012_460518 | 0.58 |
SHC2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
731 |
0.5 |
chr11_104034118_104035249 | 0.58 |
PDGFD |
platelet derived growth factor D |
152 |
0.98 |
chr14_105881008_105881234 | 0.58 |
RP11-521B24.3 |
|
4955 |
0.13 |
chr19_291075_291310 | 0.58 |
PPAP2C |
phosphatidic acid phosphatase type 2C |
22 |
0.97 |
chr12_3308931_3310293 | 0.57 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr7_45002030_45002849 | 0.57 |
RP4-647J21.1 |
|
1931 |
0.25 |
chr9_138370943_138371341 | 0.57 |
PPP1R26 |
protein phosphatase 1, regulatory subunit 26 |
217 |
0.86 |
chr11_110582275_110583137 | 0.57 |
ARHGAP20 |
Rho GTPase activating protein 20 |
67 |
0.99 |
chr7_73867713_73868217 | 0.57 |
GTF2IRD1 |
GTF2I repeat domain containing 1 |
155 |
0.96 |
chr7_100815549_100815705 | 0.57 |
VGF |
VGF nerve growth factor inducible |
6753 |
0.1 |
chr11_98891048_98891497 | 0.57 |
CNTN5 |
contactin 5 |
599 |
0.85 |
chr17_72427609_72428169 | 0.57 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
222 |
0.91 |
chr12_16758688_16759086 | 0.57 |
LMO3 |
LIM domain only 3 (rhombotin-like 2) |
17 |
0.99 |
chr11_64002356_64003048 | 0.56 |
VEGFB |
vascular endothelial growth factor B |
410 |
0.51 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.6 | 1.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 1.3 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.4 | 2.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.3 | 2.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 0.6 | GO:0060433 | bronchus development(GO:0060433) |
0.3 | 0.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 0.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.3 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 1.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.7 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.7 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.5 | GO:0072070 | loop of Henle development(GO:0072070) |
0.2 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 0.2 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.2 | 0.3 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 1.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.3 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.2 | 0.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.9 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.4 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.4 | GO:0003416 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.1 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) response to histamine(GO:0034776) |
0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 1.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 1.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.3 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 1.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.3 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.4 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.5 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.7 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.3 | GO:0061383 | trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
0.1 | 1.0 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.8 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:1904238 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.4 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.7 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.8 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0072087 | renal vesicle development(GO:0072087) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 1.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.3 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.0 | 0.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.4 | GO:0071450 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.3 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 1.1 | GO:0022405 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.5 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0045979 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.2 | GO:0048512 | circadian sleep/wake cycle(GO:0042745) circadian behavior(GO:0048512) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 1.0 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 2.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 3.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 1.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0010882 | negative regulation of heart rate(GO:0010459) regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.6 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.5 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.2 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.2 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.1 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.3 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0001714 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.5 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.3 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0014812 | muscle cell migration(GO:0014812) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:1903170 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.6 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 1.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.4 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.0 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.0 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.3 | GO:0045981 | positive regulation of nucleotide metabolic process(GO:0045981) positive regulation of purine nucleotide metabolic process(GO:1900544) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.4 | GO:1900274 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.0 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 1.8 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 1.7 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.4 | GO:0043588 | skin development(GO:0043588) |
0.0 | 0.4 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.0 | 0.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.2 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0002724 | T cell cytokine production(GO:0002369) regulation of T cell cytokine production(GO:0002724) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 1.0 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 1.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.6 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 0.7 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 1.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.6 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 2.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 15.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 1.9 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 2.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 2.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 10.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 1.1 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.8 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 0.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 2.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 2.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 1.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.7 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 2.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.4 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.9 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.8 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 2.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 2.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 1.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 1.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.1 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 1.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 4.3 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 1.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 1.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 1.0 | GO:1901681 | sulfur compound binding(GO:1901681) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 11.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 2.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 3.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 4.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 3.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 2.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |